Journal of Ocular Infection and Inflammation

Stangogiannis-Druya Crisanti

Publications

• Research Article
  Efficacy of Nepafenac 0.3% Plus Dexamethasone 0.1% Versus Dexamethasone Alone in Prophylaxis of Irvine-Gass Syndrome After Cataract Surgery
  
  Author(s): Stangogiannis-Druya Crisanti and Stangogiannis-Druya EvangeliaStangogiannis-Druya Crisanti and Stangogiannis-Druya Evangelia
  
  Purpose: To determine whether nepafenac ophthalmic suspension 0.3% in co-administration with dexamethasone 0.1%, effectively reduces the incidence of Irvine-Gass syndrome, after uneventful cataract surgery. Setting: Laserlens One Day Clinic. Ioannina-Greece Design: Prospective, comparative, interventional and randomized study. (N=200). Methods: We included 200 eyes that required phacoemulsification and uncomplicated cataract surgery. Patients were randomly divided into two groups: first group (right eye) included nepafenac 0.3% + dexamethasone 0.1% ophthalmic suspension. Second group (left eye) included dexamethasone 0.1% alone. On thirtieth and ninetieth day after surgery optical coherence tomography was carried out; fluorescein retinal angiography study was performed to confirm the CME. .. View More»
  

  Abstract